Wuhan Dazhong Dental Medical Co., Ltd. released its July 2026 monthly return, disclosing a placement-driven expansion of both authorised and issued share capital.

Authorised / Registered Capital • H-share authorised/registered capital increased by 1.20 million shares to 18.23 million shares, each with a par value of RMB 1. • Unlisted domestic shares remained unchanged at 32.35 million shares. • Aggregate authorised/registered capital now totals RMB 50.58 million.

Issued Share Movements • Issued H-shares (excluding treasury shares) grew from 17.03 million to 18.23 million, reflecting the new placement. • No treasury shares were outstanding or transacted during the period. • Unlisted domestic share count was steady at 32.35 million.

Placement Details • On 15 July 2026, the company completed a placing/subscription of 1.20 million new H-shares at HKD 10.00 per share, following shareholder approval on 29 May 2026. • These new shares represent a 7.0% month-on-month increase in the H-share float.

Public Float Compliance • Management confirmed that, as of 31 July 2026, the company met the Main Board’s minimum 25% public float requirement for its H-shares.

Regulatory Confirmation • Chairman and Executive Director Yao Xue certified that all issuance procedures complied with Hong Kong Listing Rules, relevant laws and regulatory requirements, and that all proceeds have been duly received.

With the latest issuance, Dazhong Dental’s enlarged H-share base strengthens its capital structure while maintaining full adherence to listing and public float obligations.